GGrantIndex
Sort

78,016 grants matching breast cancer

An in vivo metastasis sensor

$834,930
Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2016 · CA

TRANSFORMING TRIPLE-NEGATIVE BREAST CANCER TREATMENT THROUGH INTRATUMORAL IMMUNOTHERAPY VIA NANOFLUIDIC DRUG-ELUTING SEED

$834,791
The Methodist Hospital Research Institute · · FY2020 · Defense Health Agency

The TOPAS Tool for Particle Simulation, a Monte Carlo Simulation Tool for Physics, Biology and Clinical Research

$834,762
Bruce Faddegon · University Of California, San Francisco · U24 · FY2020 · CA

Pharmacogenomics of Microtubule Targeting Agents

$834,690
Deanna L Kroetz · University Of California, San Francisco · R01 · FY2016 · CA

Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing

$834,674
Charles M Perou · Univ Of North Carolina Chapel Hill · U24 · FY2010 · CA

Directed Transport Physics and Muli-Scale Therapy of Colon Cancer Liver Metatasis

$834,620
Mauro Ferrari · University Of Texas Hlth Sci Ctr Houston · U54 · FY2010 · CA

Radiation-induced translational control of gene expression

$834,513
Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Mechanisms of DNA Homology-directed Genome Repair and Tumor Suppression

$834,337
Patrick Sung · University Of Texas Hlth Science Center · R35 · FY2024 · CA

Molecular Orgin Cancer--Catechol Estrogen 3 4 Quinones

$834,167
University Of Nebraska Medical Center · P01 · FY2004 · CA

BIOSTATISTICS/BIOINFORMATICS

$834,037
Peter D Emanuel · University Of Alabama At Birmingham · P30 · FY2009 · CA

Germline modifiers of tumor progression and metastasis

$834,027
Nigel Crawford · National Human Genome Research Institute · ZIA · FY2011 · HG

Marshfield Community Clinical Oncology Program

$834,025
Marshfield Clinic Research Foundation · U10 · FY2005 · CA

Premonopausal Hormone Levels and Risk of Breast Cancer

$833,942
Susan E. Hankinson · Harvard School Of Public Health · R01 · FY2010 · CA

Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors

$833,902
Rachel Ann Freedman · Dana-Farber Cancer Inst · R01 · FY2025 · AG

The optimization of compounds that selectively inhibit protein synthesis for the

$833,819
Cathy A Swindlehurst · Novomedix, Inc. · R44 · FY2013 · CA

RODENT PRODUCTION CENTER

$833,803
Taconic Farms, Inc. · N01 · FY2000 · ES

Functional genomics of breast cancer

$833,613
Paul S. Meltzer · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Discovery Expansion and Replication

$833,399
Brian E Henderson · University Of Southern California · U19 · FY2012 · CA

Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal

$833,394
Thomas Lad · Hektoen Institute For Medical Research · UG1 · FY2019 · CA

Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal

$833,394
Thomas Lad · Hektoen Institute For Medical Research · UG1 · FY2020 · CA

Quantitative Biophotonics for Tissue Characterization and Function

$833,246
Amir H Gandjbakhche · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD

Bupropion for smoking cessation during pregnancy

$833,182
Gary D Hankins · University Of Texas Med Br Galveston · R01 · FY2010 · DA

OLDER BREAST CANCER PATIENTS: RISK FOR COGNITIVE DECLINE

$833,064
Jeanne Mandelblatt · Georgetown University · R01 · FY2010 · CA

The VITamin D and OmegA-3 TriaL (VITAL): Post-Intervention Follow-Up

$833,001
Joann Elisabeth Manson · Brigham And Women'S Hospital · R01 · FY2024 · AT

Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion

$832,771
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA